The first medication created solely for the prevention of migraine headaches is now on the market in Australia, but for $800 per month.
Migraines are one of the most common medical afflictions in Australia, impacting 4.9 million people.
Given how migraines affect the lives of those who suffer from them, it may surprise you to learn that until very recently there were no drugs specifically for the prevention of migraine headaches.
Chronic sufferers seeking relief must take serious medications, originally designed to treat other conditions, such as anti-convulsants for seizure prevention, beta-blockers that reduce your blood-pressure and large doses of Botox, primarily used in aesthetic anti-wrinkle injections.
And with current medications causing significant side effects, a new medicine has been developed to specifically to prevent the intensity, duration and frequency that people experience migraine headaches
Aimovig is a self-administered, once-monthly injection that basically works by inhibiting a chemical process believed to be one of the central causes of migraines - and it is working for people!
According to Dr Sait Ashina, a neurologist specialising in headache treatment at the Beth Israel Deaconess Medical Center, Boston, Massachusetts, patients taking Aimovig suffered around half the amount of headache days of those who did not take the medication.
"I have had very good success with these medications,” Dr Ashina told Harvard Medical School .“The majority of my patients with severe migraine headaches are responding well, with few side effects."
Unfortunately, however, these drugs aren't cheap. Aimovig costs $800 per month and is currently not listed under Australia's nationalised health coverage, so it's a significant out of pocket expense that is inaccessible to many.